This joint publication between GlaxoSmithKline and Accelrys shows LibDock is one of the top performers among ten docking programs (Glide, GOLD, FlexX, Fred, MOE, Dock4, and others) when applied to eight receptor targets. Specific successes with LibDock include:

Best recovery of X-ray pose for HCV Polymerase and Factor Xa
Best enrichment of actives after within 10% of scored compounds in a virtual screening experiment with Gyrase B Isomerase

Request the Publication,"Validation Studies of the Site-Directed Docking Program LibDock"

Fill out the form below to request your free copy. A follow-up email will be sent to the email address you provide on the form.

Contact Information

Salutation*
(Required) other:
First Name*
(Required)
Last Name*
(Required)
Organization*
(Required)
Organization Type*
(Required)
City*
(Required)
State/Province (US/Canada only)*
(Required)
State/Province (other)
(Required)
Zip/Postal Code*
(Required)
Country*
(Required)
Phone*
Required: a valid telephone number (no letters)
Email*
Required: a valid email address

Disclaimer

Accelrys will store the data you have provided in a database which is accessible by appropriate personnel who have a business need for the information. For full details on our privacy policy please see http://accelrys.com/company/legal/

Accelrys may contact me by e-mail with updates and information on products or services

Accelrys may share the information I have provided with its strategic partners, who may contact me about related products or services

Careers | Legal / Terms of Use | Contact us